businesspress24.com - ZoomMed: Grant of Options (Rectification)
 

ZoomMed: Grant of Options (Rectification)

ID: 1139374

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwire) -- 08/03/12 -- ZoomMed inc. (TSX VENTURE: ZMD) announced, on July 20, 2012, that its Board of directors agreed to grant 2,700,000 stock options to its directors and officers and 1,130,000 stock options to its employees and consultants.

The exercise price of these stock options is rectified to $0.10, to comply with the TSX Venture Exchange policy 1.1.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
ZoomMed
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, ext 228




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Rosetta Genomics Announces Pricing of Public Offering of 5.5 Million Ordinary Shares
CompuMed Contract Extended With Oklahoma Department of Corrections
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 03.08.2012 - 12:21 Uhr
Sprache: Deutsch
News-ID 1139374
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

MONTREAL, QUEBEC


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 244 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ZoomMed: Grant of Options (Rectification)
"
steht unter der journalistisch-redaktionellen Verantwortung von

ZoomMed Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von ZoomMed Inc.



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 154


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.